Opinion
Video
Navigating Myelofibrosis Transitions
Robert Mancini, PharmD, and Victoria Nachar, PharmD, discuss strategies and resources for smooth inpatient to outpatient transitions in myelofibrosis care, highlighting medication reconciliation, financial assistance, and the need for dedicated support staff.
This is a video synopsis/summary of a Peer Exchange involving Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; Shawn Griffin, PharmD, BCOP; and Robert Mancini, PharmD, BCOP, FHOPA.
In this segment, Mahmoudjafari asks Mancini about success stories or best practices for smooth transitions from inpatient to outpatient care for myelofibrosis patients. Mancini emphasizes the need for increased focus on transitions of care at higher levels and stresses the importance of caring more about this process. He acknowledges the literature’s role in highlighting pharmacist roles in transitions of care and underlines the crucial role of medication reconciliation. Mancini shares the significance of early involvement in the prescription process during a patient’s admission, emphasizing the importance of familiarity with assistance programs and collaboration with financial advocates. He praises the role of dedicated staff, including high-level technicians, in navigating financial challenges. Mahmoudjafari then turns to Nachar to discuss tools and resources available at her organization, such as specialty pharmacy technicians and pharmacists. Nachar emphasizes education, mentioning resources from the Academy of Oncology Nurse & Patient Navigators and advocating for multidisciplinary oncology pharmacist research to develop validated tools for predicting high-risk patients. The discussion highlights the need for a collective effort and specialized support to navigate the complexities of myelofibrosis patient care transitions.
This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.
